Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
Authors
Keywords
-
Journal
Cancers
Volume 6, Issue 3, Pages 1298-1327
Publisher
MDPI AG
Online
2014-06-27
DOI
10.3390/cancers6031298
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/EnzalutamideversusAnti-androgen Receptor ASC-J9® Lead to PromotionversusSuppression of Prostate Cancer Metastasis
- (2013) Tzu-Hua Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival
- (2013) Ferhat Ozden et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6->Androgen Receptor->TGF- ->MMP-9 Signals
- (2013) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Semagacestat for Treatment of Alzheimer's Disease
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- (2013) Andrei Moroz et al. PLoS One
- Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells
- (2013) Aditi Gupta et al. Cancers
- Fibronectin induces MMP2 expression in human prostate cancer cells
- (2012) Andrei Moroz et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study
- (2012) Robert W Ross et al. LANCET ONCOLOGY
- Androgen deprivation by flutamide modulates uPAR, MMP-9 expressions, lipid profile, and oxidative stress: amelioration by daidzein
- (2012) Abdul Lateef et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model
- (2012) Yifeng Xia et al. NATURE CELL BIOLOGY
- ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells
- (2012) SOOK SHIN et al. ONCOLOGY REPORTS
- SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells
- (2012) Jenna D. Lovaas et al. PROSTATE
- An Alternate Perspective on the Roles of TIMPs and MMPs in Pathology
- (2011) Craig S. Moore et al. AMERICAN JOURNAL OF PATHOLOGY
- Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression
- (2011) B Scaggiante et al. BRITISH JOURNAL OF CANCER
- Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome
- (2011) Mingguo Huang et al. CARCINOGENESIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line
- (2011) Qinwen Wang et al. CELL BIOLOGY INTERNATIONAL
- Overexpression of MMP-9 Contributes to Invasiveness of Prostate Cancer Cell Line LNCaP
- (2011) Ravikumar Aalinkeel et al. IMMUNOLOGICAL INVESTIGATIONS
- LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: implication in invasion of prostate cancer cells
- (2011) Tenekua Tapia et al. Molecular Cancer
- Oxidative Stress and Prostate Cancer Progression Are Elicited by Membrane-Type 1 Matrix Metalloproteinase
- (2011) H.-L. Nguyen et al. MOLECULAR CANCER RESEARCH
- Tissue inhibitors of metalloproteinases
- (2011) Gillian Murphy GENOME BIOLOGY
- Matrix Metalloproteinases and Angiogenic Factors
- (2010) Silvan Boxler et al. AMERICAN JOURNAL OF PATHOLOGY
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
- (2010) Keith Brew et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients
- (2010) William K. Oh et al. CANCER
- Targeting MMP-9, uPAR and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells
- (2010) A K Nalla et al. CANCER GENE THERAPY
- Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-Dependent Prostate Cancer Cell Migration
- (2010) A. L. Sabbota et al. CANCER RESEARCH
- Matrix Metalloproteinases Contribute Distinct Roles in Neuroendocrine Prostate Carcinogenesis, Metastasis, and Angiogenesis Progression
- (2010) L. E. Littlepage et al. CANCER RESEARCH
- Matrix Metalloproteinase-9 Regulates Tumor Cell Invasion through Cleavage of Protease Nexin-1
- (2010) D. Xu et al. CANCER RESEARCH
- DNA Damage-Mediated Induction of a Chemoresistant Niche
- (2010) Luke A. Gilbert et al. CELL
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Regulation of matrix metalloproteinase activity in health and disease
- (2010) Elin Hadler-Olsen et al. FEBS Journal
- Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
- (2010) Chrisostomi Gialeli et al. FEBS Journal
- Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis
- (2010) Dominique Trudel et al. HUMAN PATHOLOGY
- Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy
- (2010) Tibor Szarvas et al. INTERNATIONAL JOURNAL OF CANCER
- Runx3 suppresses gastric cancer metastasis through inactivation of MMP9 by upregulation of TIMP-1
- (2010) Yu Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
- (2010) David S Yee et al. Molecular Cancer
- Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF
- (2010) Thomas R Johnson et al. Molecular Cancer
- Osteoclast-Derived Matrix Metalloproteinase-9 Directly Affects Angiogenesis in the Prostate Tumor-Bone Microenvironment
- (2010) A. Bruni-Cardoso et al. MOLECULAR CANCER RESEARCH
- Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor
- (2010) M. Crocker et al. NEURO-ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model
- (2010) X Yu et al. ONCOGENE
- High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome
- (2010) Bahir Aldulaymi et al. ONCOLOGY
- The metzincins - Topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a super family of zinc-peptidases
- (2010) Walter Stöcker et al. PROTEIN SCIENCE
- Review: Castration-resistant prostate cancer: new science and therapeutic prospects
- (2010) Joaquim Bellmunt et al. Therapeutic Advances in Medical Oncology
- E1AF expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer
- (2009) SUGURE MARUTA et al. APMIS
- Osteoclast-Derived Matrix Metalloproteinase-7, but Not Matrix Metalloproteinase-9, Contributes to Tumor-Induced Osteolysis
- (2009) S. Thiolloy et al. CANCER RESEARCH
- Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer
- (2009) Takaki Yoshikawa et al. Gastric Cancer
- Increased Aggressiveness of Human Prostate PC-3 Tumor Cells Expressing Cell Surface Localized Membrane Type-1 Matrix Metalloproteinase (MT1-MMP)
- (2009) X. Wang et al. JOURNAL OF ANDROLOGY
- The prognostic value of TIMP-1 in multiple myeloma
- (2009) Liliana Guedez et al. LEUKEMIA RESEARCH
- Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells
- (2008) T.-K. Ito et al. BLOOD
- TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro
- (2008) Rebecca L. H. Bigelow et al. BREAST CANCER RESEARCH AND TREATMENT
- Activation of Matrix Metalloproteinase-2 (MMP-2) by Membrane Type 1 Matrix Metalloproteinase through an Artificial Receptor for ProMMP-2 Generates Active MMP-2
- (2008) Yuki Nishida et al. CANCER RESEARCH
- Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species
- (2008) R. Roy et al. CLINICAL CANCER RESEARCH
- Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma
- (2008) Yuichiro YOSHINO et al. JOURNAL OF DERMATOLOGY
- Novel MMP-9 Substrates in Cancer Cells Revealed by a Label-free Quantitative Proteomics Approach
- (2008) Danmei Xu et al. MOLECULAR & CELLULAR PROTEOMICS
- Molecular Dissection of the Structural Machinery Underlying the Tissue-invasive Activity of Membrane Type-1 Matrix Metalloproteinase
- (2008) Xiao-Yan Li et al. MOLECULAR BIOLOGY OF THE CELL
- Differential localization of MT1-MMP in human prostate cancer tissue: Role of IGF-1R in MT1-MMP expression
- (2008) Isis C. Sroka et al. PROSTATE
- Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
- (2008) Hideaki Miyake et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started